Changing Clinical Trial Enrollment Criteria Dramatically Increases Participation of Eligible Patients with Lung Cancer - Onco'Zine
A study, funded in part by the American Society of Clinical Oncology (ASCO) scanning more than 10,500 health records of patients with advanced non-small cell lung cancer (aNSCLC) included in the CancerLinQ database found that the use of expanded clinical trial inclusion criteria, as proposed by ASCO and Friends of Cancer Research in 2017, would nearly double the percentage of patients eligible to enroll in clinical trials.